The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano A, Zhang S, Ribback S, Steinmann S, Sini M, Ament CE, Utpatel K, Song X, Wang J, Pilo MG, Berger F, Wang H, Tao J, Li X, Pes GM, Mancarella S, Giannelli G, Dombrowski F, Evert M, Calvisi DF, Chen X, Evert K.
Cigliano A, et al. Among authors: sini m.
J Exp Clin Cancer Res. 2022 Jun 3;41(1):192. doi: 10.1186/s13046-022-02394-2.
J Exp Clin Cancer Res. 2022.
PMID: 35655220
Free PMC article.